UB Paderborn / Katalog / Suche / in CDI

Prediabetes and the risk of cancer: a meta-analysis

Diabetologia, 2014-11, Vol.57 (11), p.2261-2269

2014

Link zum Volltext

Verfügbarkeit prüfen

Pattern of distant metastases in colorectal cancer: a SEER based study

Oncotarget, 2015-11, Vol.6 (36), p.38658-38666

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms

The Journal of pathology, 2020-11, Vol.252 (3), p.252-262

2020

Link zum Volltext

Verfügbarkeit prüfen

Editorial: The Role of Sex Dimorphism in Disease Susceptibility and Immune Response

Frontiers in nutrition (Lausanne), 2022-02, Vol.9, p.849563-849563

2022

Link zum Volltext

Verfügbarkeit prüfen

Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy

Supportive care in cancer, 2015-07, Vol.23 (7), p.1933-1939

2015

Link zum Volltext

Verfügbarkeit prüfen

A Comprehensive Pan-Cancer Analysis of the Regulation and Prognostic Effect of Coat Complex Subunit Zeta 1

Genes, 2023-04, Vol.14 (4), p.889

2023

Link zum Volltext

Verfügbarkeit prüfen

Preclinical development of HQP1351, a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases, for the treatment of imatinib-resistant gastrointestinal stromal tumors

Cell & bioscience, 2019-10, Vol.9 (1), p.88-88, Article 88

2019

Link zum Volltext

Verfügbarkeit prüfen

Role of Systemic Treatment for Advanced/Metastatic Gastric Carcinoma in the Third-Line Setting: A Bayesian Network Analysis

Frontiers in oncology, 2020-04, Vol.10, p.513-513

2020

Link zum Volltext

Verfügbarkeit prüfen

Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery

Tumor biology, 2017-07, Vol.39 (7), p.1010428317709638-1010428317709638

2017

Link zum Volltext

Verfügbarkeit prüfen

Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer

Clinics (São Paulo, Brazil), 2016-08, Vol.71 (8), p.449-454

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of marital status on survival of gastric adenocarcinoma patients: Results from the Surveillance Epidemiology and End Results (SEER) Database

Scientific reports, 2016-02, Vol.6 (1), p.21098-21098, Article 21098

2016

Link zum Volltext

Verfügbarkeit prüfen

Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value

Journal of Cancer, 2016-01, Vol.7 (6), p.694-701

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systematic therapy of gastric cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16063-e16063

2022

Link zum Volltext

Verfügbarkeit prüfen

A phase 1a dose-escalation, multicenter trial of anti-claudin 18.2 antibody drug conjugate CMG901 in patients with resistant/refractory solid tumors

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.352-352

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results (SEER) database

Oncotarget, 2015-10, Vol.6 (32), p.33935-33943

2015

Link zum Volltext

Verfügbarkeit prüfen

PD-1 antibody (Camrelizumab) for metastatic EBV positive gastric cancer: A prospective single-arm, open-label, phase 2 trial

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e16014-e16014

2021

Link zum Volltext

Verfügbarkeit prüfen

Incidence rate and clinic-pathologic features of EBV-associated gastric carcinoma in China

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16048-e16048

2018

Link zum Volltext

Verfügbarkeit prüfen

An open-label, single-arm, dose escalation and expansion phase 1 study of tebotelimab (MGD013) plus niraparib in patients with locally advanced or metastatic gastric cancer who failed prior treatments

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.402-402

2023

Link zum Volltext

Verfügbarkeit prüfen

Unveiling prognosis and traits of dMMR/MSI-H gastric and colorectal cancer after curative surgery: A large-scale, multi-center, retrospective study in China

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.729-729

2024

Link zum Volltext

Verfügbarkeit prüfen

A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma

Oncology research, 2020-09, Vol.28 (4), p.331-344

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical sonochemotherapy of inoperable pancreatic cancer using diagnostic ultrasound and microbubbles: a multicentre, open-label, randomised, controlled trial

European radiology, 2024-03, Vol.34 (3), p.1481-1492

2024

Link zum Volltext

Verfügbarkeit prüfen

Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors

International journal of clinical and experimental pathology, 2015-01, Vol.8 (9), p.11084-11091

2015

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.1905-1913

2019

Link zum Volltext

Verfügbarkeit prüfen

Epstein-Barr virus infection associated with pepsinogens and Helicobacter pylori infection in patients with gastric cancer

Virus research, 2018-09, Vol.256, p.1-5

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of SOXIRI (S-1/oxaliplatin/irinotecan) chemotherapy in patients with unresectable pancreatic ductal adenocarcinoma

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2024-03, Vol.24 (2), p.241-248

2024

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Prediabetes and the risk of cancer: a meta-analysis

Pattern of distant metastases in colorectal cancer: a SEER based study

Molecular characterization of organoids derived from pancreatic intraductal papillary mucinous neoplasms

Editorial: The Role of Sex Dimorphism in Disease Susceptibility and Immune Response

Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapy

A Comprehensive Pan-Cancer Analysis of the Regulation and Prognostic Effect of Coat Complex Subunit Zeta 1

Preclinical development of HQP1351, a multikinase inhibitor targeting a broad spectrum of mutant KIT kinases, for the treatment of imatinib-resistant gastrointestinal stromal tumors

Role of Systemic Treatment for Advanced/Metastatic Gastric Carcinoma in the Third-Line Setting: A Bayesian Network Analysis

Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery

Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer

Impact of marital status on survival of gastric adenocarcinoma patients: Results from the Surveillance Epidemiology and End Results (SEER) Database

Pathologic Diagnosis of Pancreatic Adenocarcinoma in the United States: Its Status and Prognostic Value

Comparison of response evaluation criteria in solid tumors and tumor regression grade in evaluating the effect of preoperative systematic therapy of gastric cancer

A phase 1a dose-escalation, multicenter trial of anti-claudin 18.2 antibody drug conjugate CMG901 in patients with resistant/refractory solid tumors

Comparison of survival and clinicopathologic features in colorectal cancer among African American, Caucasian, and Chinese patients treated in the United States: Results from the surveillance epidemiology and end results (SEER) database

PD-1 antibody (Camrelizumab) for metastatic EBV positive gastric cancer: A prospective single-arm, open-label, phase 2 trial

Incidence rate and clinic-pathologic features of EBV-associated gastric carcinoma in China

An open-label, single-arm, dose escalation and expansion phase 1 study of tebotelimab (MGD013) plus niraparib in patients with locally advanced or metastatic gastric cancer who failed prior treatments

Unveiling prognosis and traits of dMMR/MSI-H gastric and colorectal cancer after curative surgery: A large-scale, multi-center, retrospective study in China

A Novel BCL-2 Inhibitor APG-2575 Exerts Synthetic Lethality With BTK or MDM2-p53 Inhibitor in Diffuse Large B-Cell Lymphoma

Clinical sonochemotherapy of inoperable pancreatic cancer using diagnostic ultrasound and microbubbles: a multicentre, open-label, randomised, controlled trial

Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors

Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms

Epstein-Barr virus infection associated with pepsinogens and Helicobacter pylori infection in patients with gastric cancer

Phase II study of SOXIRI (S-1/oxaliplatin/irinotecan) chemotherapy in patients with unresectable pancreatic ductal adenocarcinoma

Suchergebnisse filtern